Genentech's historical stock symbol was DNA.
A stock symbol, also known as a ticker symbol, is a unique series of letters assigned to a security for trading on a particular stock exchange. It serves as an identification code for a company's shares.
Genentech's Ticker Symbol: DNA
When Genentech, Inc. was a publicly traded company, its shares were listed on the New York Stock Exchange (NYSE) under the ticker symbol DNA. This memorable symbol was a direct nod to the company's pioneering work in biotechnology and genetic engineering, specifically its foundational role in recombinant DNA technology.
While the symbol DNA is historically associated with Genentech, it's important to understand the company's current status in the market.
Current Status of Genentech Shares
Genentech, Inc. is no longer an independent, publicly traded entity with its own stock symbol. In 2009, Swiss pharmaceutical giant Roche Holding AG completed its acquisition of Genentech, making it a wholly-owned subsidiary. Consequently, Genentech's shares were delisted from the stock exchange, and its DNA ticker symbol is no longer active for trading purposes. Investors interested in the performance of Genentech's operations would now look to the financial results of its parent company, Roche.
Here’s a quick overview:
| Aspect | Details |
|---|---|
| Company Name | Genentech, Inc. |
| Historical Stock Symbol | DNA |
| Historical Exchange | New York Stock Exchange (NYSE) |
| Current Status | Wholly-owned subsidiary of Roche Holding AG |
| Shares Traded | No longer traded independently under DNA symbol |
Understanding the Importance of Stock Symbols
Stock symbols are crucial for:
- Easy Identification: They allow investors and traders to quickly identify specific companies on trading platforms.
- Trading Efficiency: Streamlining the process of buying and selling shares.
- Market Data Access: Enabling efficient retrieval of price quotes, historical data, and news for a specific company.
Although Genentech's DNA symbol is now part of its rich history, its legacy in biotechnology and its impact on the pharmaceutical industry continue to be significant under the Roche umbrella.
